Reinhard Schneppenheim

Universität Hamburg

Papers

1

Total Citations

30

H-Index

1

About

Reinhard Schneppenheim is a leading figure in hemostasis research, whose work has fundamentally advanced the understanding and diagnosis of von Willebrand disease (VWD). His key research areas encompass the molecular genetics, pathophysiology, and clinical management of bleeding disorders, with a particular focus on von Willebrand factor (VWF). Schneppenheim’s major contributions include pioneering the genetic characterization of VWD subtypes, which has refined classification and enabled personalized treatment strategies. Notably, he played a central role in the European multicenter study MCMDM-1VWD, which validated the VWF-LIA rapid test for quantitative determination of VWF antigen in type 1 VWD diagnosis—a study that has garnered over 30 citations and improved diagnostic accuracy worldwide. His work has also elucidated the molecular mechanisms of VWF mutations, linking genotype to phenotype in severe forms of the disease. With a career spanning decades, Schneppenheim’s research has been cited extensively, reflecting its profound impact on clinical practice. His achievements include leadership in international consortia and mentorship of a new generation of coagulation scientists, cementing his legacy as a pioneer in the field of inherited bleeding disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD
30 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Universität Hamburg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago